{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:38:37Z","timestamp":1779201517558,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2017QH005"],"award-info":[{"award-number":["ZR2017QH005"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023MH260"],"award-info":[{"award-number":["ZR2023MH260"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803097"],"award-info":[{"award-number":["81803097"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.prp.2025.156138","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T15:03:58Z","timestamp":1752937438000},"page":"156138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Alendronate-functionalized ZIF-8 nanoplatform for targeted delivery of SHH siRNA and docetaxel to treat prostate cancer bone metastasis"],"prefix":"10.1016","volume":"273","author":[{"given":"Hui","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiamin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longquan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianxian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prp.2025.156138_bib1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin. CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.prp.2025.156138_bib2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11427-023-2423-1","article-title":"Cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors","volume":"67","author":"He","year":"2024","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.prp.2025.156138_bib3","article-title":"Translating preclinical insights into clinical strategies: targeting cancer stem cells and stemness in prostate cancer","volume":"269","author":"Daneshi","year":"2025","journal-title":"Pathol. Res Pr."},{"issue":"5","key":"10.1016\/j.prp.2025.156138_bib4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1158\/1535-7163.MCT-23-0420","article-title":"Darolutamide added to docetaxel augments antitumor effect in models of prostate cancer through cell cycle arrest at the G1-S transition","volume":"23","author":"Buck","year":"2024","journal-title":"Mol. Cancer Ther."},{"issue":"8","key":"10.1016\/j.prp.2025.156138_bib5","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/s41416-024-02614-w","article-title":"Capivasertib combines with docetaxel to enhance anti-tumour activity through inhibition of AKT-mediated survival mechanisms in prostate cancer","volume":"130","author":"Eberlein","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2025.156138_bib6","article-title":"Synergistic effect of docetaxel combined with a novel multi-target inhibitor CUDC-101 on inhibiting human prostate cancer","volume":"252","author":"Li","year":"2023","journal-title":"Pathol. Res. Pr."},{"issue":"1","key":"10.1016\/j.prp.2025.156138_bib7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1158\/1541-7786.MCR-21-0108","article-title":"GLI3 is stabilized by SPOP mutations and promotes castration resistance via functional cooperation with androgen receptor in prostate cancer","volume":"20","author":"Burleson","year":"2022","journal-title":"Mol. Cancer Res"},{"issue":"4","key":"10.1016\/j.prp.2025.156138_bib8","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1007\/s11033-021-06387-w","article-title":"Sonic hedgehog signaling is associated with resistance to zoledronic acid in CD133high\/CD44high prostate cancer stem cells","volume":"48","author":"Acikgoz","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"3","key":"10.1016\/j.prp.2025.156138_bib9","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ccell.2017.02.003","article-title":"MAOA-dependent activation of Shh-IL6-RANKL signaling network promotes prostate cancer metastasis by engaging tumor-stromal cell interactions","volume":"31","author":"Wu","year":"2017","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.prp.2025.156138_bib10","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/s41467-021-21976-w","article-title":"Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.prp.2025.156138_bib11","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nsmb.1833","article-title":"DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS","volume":"17","author":"Fendrich","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.prp.2025.156138_bib12","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.2147\/IJN.S447350","article-title":"The application of nanoparticles targeting cancer-associated fibroblasts","volume":"19","author":"Huang","year":"2024","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.prp.2025.156138_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174178","article-title":"siRNA: mechanism of action, challenges, and therapeutic approaches","volume":"905","author":"Alshaer","year":"2021","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.prp.2025.156138_bib14","article-title":"Advancements of gene therapy in cancer treatment: a comprehensive review","volume":"261","author":"Mohd Abas","year":"2024","journal-title":"Pathol. Res Pr."},{"issue":"2","key":"10.1016\/j.prp.2025.156138_bib15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s40120-020-00208-1","article-title":"A review of patisiran (ONPATTRO\u00ae) for the treatment of polyneuropathy in people with hereditary transthyretin amyloidosis","volume":"9","author":"Urits","year":"2020","journal-title":"Neurol. Ther."},{"issue":"11","key":"10.1016\/j.prp.2025.156138_bib16","doi-asserted-by":"crossref","first-page":"9529","DOI":"10.1007\/s11033-023-08749-y","article-title":"Advances in siRNA delivery approaches in cancer therapy: challenges and opportunities","volume":"50","author":"Isazadeh","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.prp.2025.156138_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.prp.2025.156138_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2021.131926","article-title":"Bioinspired metal\u2013organic frameworks mediated efficient delivery of siRNA for cancer therapy","volume":"426","author":"Zhang","year":"2021","journal-title":"Chem. Eng. J."},{"issue":"17","key":"10.1016\/j.prp.2025.156138_bib19","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1039\/D3TB02827E","article-title":"A biomimetic camouflaged metal organic framework for enhanced siRNA delivery in the tumor environment","volume":"12","author":"Tao","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.prp.2025.156138_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2021.129386","article-title":"Metal-organic frameworks for simultaneous gene and small molecule delivery in vitro and in vivo","volume":"418","author":"Ringaci","year":"2021","journal-title":"Chem. Eng. J."},{"issue":"18","key":"10.1016\/j.prp.2025.156138_bib21","doi-asserted-by":"crossref","first-page":"8689","DOI":"10.1039\/D4NR01056F","article-title":"Recent advances in targeted drug delivery for the treatment of glioblastoma","volume":"16","author":"Mao","year":"2024","journal-title":"Nanoscale"},{"issue":"19","key":"10.1016\/j.prp.2025.156138_bib22","doi-asserted-by":"crossref","first-page":"6501","DOI":"10.1039\/D1BM01006A","article-title":"A NIR-triggered multifunctional nanoplatform mediated by Hsp70 siRNA for chemo-hypothermal photothermal synergistic therapy","volume":"9","author":"Zhang","year":"2021","journal-title":"Biomater. Sci."},{"issue":"Pt 1","key":"10.1016\/j.prp.2025.156138_bib23","article-title":"Tumor-targeted delivery of SNHG15 siRNA using a ZIF-8 nanoplatform: towards a more effective prostate cancer therapy","volume":"259","author":"Saeinasab","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"10","key":"10.1016\/j.prp.2025.156138_bib24","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1177\/0885328219836540","article-title":"Doxorubicin-loaded Fe3O4-ZIF-8 nano-composites for hepatocellular carcinoma therapy","volume":"33","author":"Cheng","year":"2019","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.prp.2025.156138_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2022.09.002","article-title":"Stealth nanoparticles in oncology: facing the PEG dilemma","volume":"351","author":"Zalba","year":"2022","journal-title":"J. Control Release"},{"issue":"2","key":"10.1016\/j.prp.2025.156138_bib26","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1021\/bp990154m","article-title":"Bisphosphonate conjugation to proteins as a means to impart bone affinity","volume":"16","author":"Uludag","year":"2000","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.prp.2025.156138_bib27","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.2147\/DDDT.S337925","article-title":"New progress in improving the delivery methods of bisphosphonates in the treatment of bone tumors","volume":"15","author":"Zhong","year":"2021","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.prp.2025.156138_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.688108","article-title":"Drug delivery systems for hedgehog inhibitors in the treatment of SHH-medulloblastoma","volume":"9","author":"Caimano","year":"2021","journal-title":"Front Chem."},{"issue":"Pt B","key":"10.1016\/j.prp.2025.156138_bib29","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.addr.2015.11.017","article-title":"Heterogeneity of tumor cells in the bone microenvironment: mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer","volume":"99","author":"Futakuchi","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.prp.2025.156138_bib30","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/10717544.2022.2050845","article-title":"Bone-targeted nanoplatform enables efficient modulation of bone tumor microenvironment for prostate cancer bone metastasis treatment","volume":"29","author":"Zhang","year":"2022","journal-title":"Drug Deliv."},{"issue":"6","key":"10.1016\/j.prp.2025.156138_bib31","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.18632\/oncotarget.2932","article-title":"Inhibition of hedgehog signaling improves the anti-carcinogenic effects of docetaxel in prostate cancer","volume":"6","author":"Mimeault","year":"2015","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.prp.2025.156138_bib32","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/pros.24348","article-title":"Overexpression of regucalcin blocks the migration, invasion, and bone metastatic activity of human prostate cancer cells: crosstalk between cancer cells and bone cells","volume":"82","author":"Yamaguchi","year":"2022","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.prp.2025.156138_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/10717544.2020.1856225","article-title":"The optimized drug delivery systems of treating cancer bone metastatic osteolysis with nanomaterials","volume":"28","author":"Cheng","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.prp.2025.156138_bib34","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jconrel.2017.11.009","article-title":"Drug delivery systems functionalized with bone mineral seeking agents for bone targeted therapeutics","volume":"269","author":"Rotman","year":"2018","journal-title":"J. Control Release"},{"issue":"1","key":"10.1016\/j.prp.2025.156138_bib35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s13346-022-01191-w","article-title":"Management of bone diseases: looking at scaffold-based strategies for drug delivery","volume":"13","author":"Bordone","year":"2023","journal-title":"Drug Deliv. Transl. Res"},{"issue":"6","key":"10.1016\/j.prp.2025.156138_bib36","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1021\/acsabm.1c00199","article-title":"Alendronate-decorated nanoparticles as bone-targeted alendronate carriers for potential osteoporosis treatment","volume":"4","author":"Jing","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"issue":"1-2","key":"10.1016\/j.prp.2025.156138_bib37","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ijpharm.2016.11.051","article-title":"Calcium phosphate nanoparticles functionalized with alendronate-conjugated polyethylene glycol (PEG) for the treatment of bone metastasis","volume":"516","author":"Chu","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.prp.2025.156138_bib38","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1021\/acs.molpharmaceut.8b01343","article-title":"Alendronate-modified polymeric micelles for the treatment of breast cancer bone metastasis","volume":"16","author":"Liu","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.prp.2025.156138_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.humpath.2023.01.008","article-title":"Cribriform pattern and intraductal carcinoma of the prostate can have a clinicopathological impact, regardless of their percentage and\/or number of cores","volume":"135","author":"Okubo","year":"2023","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2025.156138_bib40","article-title":"Comparison of the clinicopathologic features of prostate cancer in US and Chinese populations","volume":"234","author":"Zhang","year":"2022","journal-title":"Pathol. Res. Pr."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825003310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825003310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:26:06Z","timestamp":1778747166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825003310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":40,"alternative-id":["S0344033825003310"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.156138","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alendronate-functionalized ZIF-8 nanoplatform for targeted delivery of SHH siRNA and docetaxel to treat prostate cancer bone metastasis","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.156138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"156138"}}